SRx Health Solutions, Inc. (SRXH): Nasdaq/NYSE listing notice — SRx Health Solutions receives NYSE American warning letter over 7.5M share issuance without approval

SRx Health Solutions, Inc.

NYSE American issued public warning letter on Feb 18, 2026 citing violations of Sections 301 and 713.
Company failed to file listing application and obtain shareholder approval for issuance of approx. 7.5 million shares upon conversion of Series A Preferred Stock.
Company had obtained stockholder approval by written consent on Oct 8, 2025, but NYSE deemed it deficient under internal guidance.
All preferred shares have been converted or redeemed as of report date; no preferred shares outstanding.
Company filed Form 8-K and press release on Feb 20, 2026 disclosing the warning letter.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

SRx Health Solutions, Inc. received a nyse_american noncompliance notice notice regarding other (rules 301, 713).

Exchange: nyse american
Notice: noncompliance notice
Rules: 301, 713

Exact text from the filing

February 18, 2026, SRx Health Solutions, Inc. (the “Company”) received a public warning letter (the “Letter”) from the NYSE Regulation Staff of the New York Stock Exchange (the “Exchange”) notifying the Company that it failed to comply with Sections 301 and 713 of the NYSE American LLC Company Guide (the “Company Guide”). The Letter relates to the issuance of approximately 7.5 million shares (the “Subject Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), between December 31, 2025 and January 23, 2026, upon conversion of certain shares of the Company’s Ser

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-007565

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.